<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.5.1//EN" "ep-patent-document-v1-5-1.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP18780393B1" file="EP18780393NWB1.xml" lang="en" country="EP" doc-number="3607933" kind="B1" date-publ="20211006" status="n" dtd-version="ep-patent-document-v1-5-1">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B005EP>J</B005EP><B007EP>BDM Ver 2.0.12 (4th of August) -  2100000/0</B007EP><B070EP>The file contains technical information submitted after the application was filed and not included in this specification</B070EP></eptags></B000><B100><B110>3607933</B110><B120><B121>EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B1</B130><B140><date>20211006</date></B140><B190>EP</B190></B100><B200><B210>18780393.7</B210><B220><date>20180403</date></B220><B240><B241><date>20191002</date></B241></B240><B250>ja</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>2017074545</B310><B320><date>20170404</date></B320><B330><ctry>JP</ctry></B330></B300><B400><B405><date>20211006</date><bnum>202140</bnum></B405><B430><date>20200212</date><bnum>202007</bnum></B430><B450><date>20211006</date><bnum>202140</bnum></B450><B452EP><date>20210614</date></B452EP></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K   8/19        20060101AFI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K   8/02        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K   8/34        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K   8/35        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61K   8/37        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61K   8/42        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>A61K   8/49        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>A61K   8/92        20060101ALI20201109BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>A61Q  19/08        20060101ALI20201109BHEP        </text></classification-ipcr></B510EP><B520EP><classifications-cpc><classification-cpc sequence="1"><text>A61K   8/34        20130101 LI20181106BHEP        </text></classification-cpc><classification-cpc sequence="2"><text>A61K2800/244       20130101 LA20201021BHEP        </text></classification-cpc><classification-cpc sequence="3"><text>A61K   8/37        20130101 LI20181106BHEP        </text></classification-cpc><classification-cpc sequence="4"><text>A61K   8/92        20130101 LI20181106BHEP        </text></classification-cpc><classification-cpc sequence="5"><text>A61Q  19/08        20130101 LI20181106BHEP        </text></classification-cpc><classification-cpc sequence="6"><text>A61K   8/0208      20130101 FI20201021BHEP        </text></classification-cpc><classification-cpc sequence="7"><text>A61K   8/494       20130101 LI20201021BHEP        </text></classification-cpc><classification-cpc sequence="8"><text>A61K   8/19        20130101 LI20181106BHEP        </text></classification-cpc><classification-cpc sequence="9"><text>A61K   8/35        20130101 LI20181106BHEP        </text></classification-cpc><classification-cpc sequence="10"><text>A61K   8/42        20130101 LI20181106BHEP        </text></classification-cpc></classifications-cpc></B520EP><B540><B541>de</B541><B542>KÖRPERKOSMETIKUM</B542><B541>en</B541><B542>BODY COSMETIC</B542><B541>fr</B541><B542>PRODUIT COSMÉTIQUE POUR LE CORPS</B542></B540><B560><B561><text>WO-A1-2013/031031</text></B561><B561><text>JP-A- 2000 319 187</text></B561><B561><text>JP-A- 2012 020 951</text></B561><B561><text>JP-A- 2012 144 474</text></B561><B561><text>JP-A- 2012 167 061</text></B561><B561><text>JP-A- 2013 018 719</text></B561><B561><text>JP-A- 2015 224 224</text></B561><B561><text>JP-A- 2016 138 064</text></B561><B561><text>US-A1- 2015 164 822</text></B561><B561><text>US-A1- 2015 250 704</text></B561><B561><text>US-A1- 2016 000 800</text></B561><B561><text>US-A1- 2017 000 704</text></B561><B562><text>CRAIGHEAD DANIEL H ET AL: "Mechanisms and time course of menthol-induced cutaneous vasodilation", MICROVASCULAR RESEARCH, ACADEMIC PRESS, US, vol. 110, 27 November 2016 (2016-11-27), pages 43-47, XP029879435, ISSN: 0026-2862, DOI: 10.1016/J.MVR.2016.11.008</text></B562><B565EP><date>20201113</date></B565EP></B560></B500><B700><B720><B721><snm>KIMURA, Shohei</snm><adr><str>c/o Kao Corporation Research Laboratories
1-3 Bunka 2-chome
Sumida-ku</str><city>Tokyo 131-8501</city><ctry>JP</ctry></adr></B721></B720><B730><B731><snm>Kao Corporation</snm><iid>100807019</iid><irf>218 012 a/scho</irf><adr><str>14-10, Nihonbashi Kayabacho 1-chome</str><city>Chuo-Ku
Tokyo 103-8210</city><ctry>JP</ctry></adr></B731></B730><B740><B741><snm>Hoffmann Eitle</snm><iid>100061036</iid><adr><str>Patent- und Rechtsanwälte PartmbB 
Arabellastraße 30</str><city>81925 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>JP2018014263</anum></dnum><date>20180403</date></B861><B862>ja</B862></B860><B870><B871><dnum><pnum>WO2018186395</pnum></dnum><date>20181011</date><bnum>201841</bnum></B871></B870></B800></SDOBI>
<description id="desc" lang="en"><!-- EPO <DP n="1"> -->
<heading id="h0001">Field of the Invention</heading>
<p id="p0001" num="0001">The present invention relates to a body cosmetic , as specified in the appended claims:<br/>
A sheet-shaped body cosmetic comprising the following components (A), (B), (C), and (D):(A) from 100 to 20,000 ppm of carbon dioxide gas,(B) a TRPM8 agonist being one or more selected from the group consisting of menthol, menthyl lactate, trimethyl isopropyl butanamide, and menthoxypropanediol,(C) 0.01 to 3% by mass of an ester oil, and(D) water.</p>
<heading id="h0002">Background of the Invention</heading>
<p id="p0002" num="0002">Long time standing job and desk work may cause fatigue, weariness, swelling or pain in each part of the body. It is widely known that promoting blood circulation by, for example, massage, stretching and taking a bath is effective for removing such symptoms.</p>
<p id="p0003" num="0003">For example, Patent Literature 1 discloses an agent for improving swelling, comprising a composition containing an agent for generating carbon dioxide gas capable of setting the concentration of carbon dioxide gas in hot water to 60 ppm or more. Patent Literature 1 describes that the agent is very effective for improving swelling in a short time by the action of carbon dioxide gas which vasodilates in a condition of high hydrostatic pressure.</p>
<p id="p0004" num="0004">It is also known that action of carbon dioxide gas on the skin promotes blood circulation in the skin even without water pressure on the body as in taking a bath. Then, studies are underway on, for example, cosmetics<!-- EPO <DP n="2"> --> containing various types of carbon dioxide gas or substances which produce carbon dioxide gas using the above characteristic.</p>
<p id="p0005" num="0005">For example, Patent Literature 2 discloses a foaming liniment for promoting skin blood circulation containing hydrocarbon, carbon dioxide and an emulsifier. Patent Literature 3 discloses a body cosmetic for promoting blood circulation containing carbon dioxide gas and TRPV3 agonist. Examples describe that attachment of a gel sheet containing carbon dioxide allows the effect of increasing blood flow to continue for 3 to 5 minutes after the attachment.</p>
<p id="p0006" num="0006">Patent Literature 4 relates to a cosmetic composition, comprising at least one oil comprising 2,000 ppm or more, preferably 5,000 ppm or more, and more preferably 8,000 ppm or more, of carbon dioxide which is dissolved in the oil, wherein the amount of the oil is more than 50% by weight, preferably more than 70% by weight, more preferably more than 90% by weight, and further more preferably 100% by weight relative to the total weight of the composition. Furthermore, Patent Literature 4 concerns a cosmetic sheet comprising at least one substrate and said cosmetic composition.</p>
<p id="p0007" num="0007">Patent Literature 5 relates to a TRPV4 activator comprising Garcinia mangostana extract as an active ingredient, as well as to a hypotension preventing or improving agent and an autonomic nerve regulator.<!-- EPO <DP n="3"> --></p>
<p id="p0008" num="0008">Furthermore, menthol is known to have the effect of promoting blood circulation (Non-patent Literature 1).</p>
<p id="p0009" num="0009">Non-patent Literature 2 describes the mechanism and time course of menthol-induced cutaneous vasodilation.</p>
<p id="p0010" num="0010">
<ul id="ul0001" list-style="none" compact="compact">
<li>(Patent Literature 1) <patcit id="pcit0001" dnum="JP2005314298A"><text>JP-A-2005-314298</text></patcit></li>
<li>(Patent Literature 2) <patcit id="pcit0002" dnum="JP2005002046A"><text>JP-A-2005-2046</text></patcit></li>
<li>(Patent Literature 3) <patcit id="pcit0003" dnum="JP2012167061A"><text>JP-A-2012-167061</text></patcit></li>
<li>(Patent Literature 3) <patcit id="pcit0004" dnum="WO2013031031A1"><text>WO 2013/031031 A1</text></patcit></li>
<li>(Patent Literature 3) <patcit id="pcit0005" dnum="JP2016138064A"><text>JP-A-2016-138064</text></patcit></li>
</ul></p>
<p id="p0011" num="0011">
<ul id="ul0002" list-style="none" compact="compact">
<li>(Non-patent Literature 1) <nplcit id="ncit0001" npl-type="s"><text>Microvascular Research 107 (2016) 39-45</text></nplcit></li>
<li>(Non-patent Literature 2) <nplcit id="ncit0002" npl-type="s"><text>CRAIGHEAD DANIEL H ET AL: "Mechanisms and time course of menthol-induced cutaneous vasodilation", vol. 110, 2016, pages 43-47</text></nplcit></li>
</ul></p>
<heading id="h0003">Summary of the Invention</heading>
<p id="p0012" num="0012">The present invention relates to a sheet-shaped body cosmetic comprising the following components (A), (B), (C), and (D):
<ol id="ol0001" compact="compact" ol-style="">
<li>(A) from 100 to 20,000 ppm of carbon dioxide gas,</li>
<li>(B) a TRPM8 agonist being one or more selected from the group consisting of menthol, menthyl lactate, trimethyl isopropyl butanamide, and menthoxypropanediol,</li>
<li>(C) an ester oil, and</li>
<li>(D) water.</li>
</ol><!-- EPO <DP n="4"> --></p>
<heading id="h0004">Detailed Description of the Drawing</heading>
<p id="p0013" num="0013">[<figref idref="f0001">Figure 1] Figure 1</figref> is a graph showing the results for the rate of increase in blood flow in Example 1 and Comparative Example 1 in Examples.</p>
<heading id="h0005">Detailed Description of the Invention</heading>
<p id="p0014" num="0014">The agent for improving swelling of Patent Literature 1 was used in limited cases and was not convenient, because it was necessary to keep applying heat and high hydrostatic pressure for 5 minutes or more.</p>
<p id="p0015" num="0015">Furthermore, although Patent Literatures 2 and 3 utilize the effect of promoting blood circulation of carbon dioxide gas, since carbon dioxide gas diffuses into the air or metabolized in the living body immediately after application to the skin, the time of keeping increased blood flow after the application of the cosmetic was not enough to improve symptoms such as fatigue, weariness, swelling and pain of the body.</p>
<p id="p0016" num="0016">Furthermore, in actual cases it took time until the effect of promoting blood circulation caused by menthol as in Non-patent Literature 1 was exhibited and the effect was too small to improve symptoms such as fatigue, weariness, swelling and pain of the body.</p>
<p id="p0017" num="0017"><!-- EPO <DP n="5"> --> The present invention provides a body cosmetic which can be applied to the body conveniently without limitation of time and place and which can increase and maintain the action of promoting blood circulation.</p>
<p id="p0018" num="0018">The present inventor conducted intensive studies to solve the above problem, and as a result found that a body cosmetic which can be applied to the body conveniently and can increase and maintain the action of promoting blood circulation for a long time can be obtained by combining a specific amount of carbon dioxide gas, a specific TRPM8 agonist and an ester oil, and completed the present invention.</p>
<p id="p0019" num="0019">Due to the combination of carbon dioxide gas, a TRPM8 agonist, and an ester oil, the body cosmetic of the present invention has an increased effect of promoting blood circulation, has an immediate and long lasting effect of promoting blood circulation, and offers comfortable tingling sensation, penetration sensation and effectiveness which have never been felt before. The body cosmetic also has excellent persistence of coolness and low skin irritation, and can be applied to the body conveniently without limitation of time and place.</p>
<p id="p0020" num="0020">The tingling sensation refers to a comfortable stimulation felt after the application of the body cosmetic, which means a feeling expecting that blood circulation is promoted.<!-- EPO <DP n="6"> --></p>
<p id="p0021" num="0021">Furthermore, the penetration sensation means a feeling as if components of the body cosmetic penetrate deeply into the body after the application of the body cosmetic.</p>
<p id="p0022" num="0022">Hereinafter the present invention will be described in detail.</p>
<p id="p0023" num="0023">The form of the body cosmetic of the present invention is optional as described later. When the body cosmetic of the present invention is in the form of a gel sheet which includes a gel layer and a sheet substrate, the portion of the gel layer without the sheet substrate corresponds to the body cosmetic of the present invention.</p>
<p id="p0024" num="0024">Furthermore, the content of the components other than component (A) means the content based on the total amount of the body cosmetic excluding component (A).</p>
<p id="p0025" num="0025">The body cosmetic of the present invention increases and maintains the action of promoting blood circulation and alleviates fatigue, weariness, swelling and pain of the body in the portion to which the cosmetic is applied. The body cosmetic contains from 100 to 20,000 ppm of (A) carbon dioxide gas based on the total amount of the body cosmetic.</p>
<p id="p0026" num="0026">The content of (A) carbon dioxide gas is preferably from 100 to 15,000 ppm, more preferably from 150 to 10,000 ppm, and further preferably from 200 to 3,000 ppm based on the total amount of the body cosmetic. A<!-- EPO <DP n="7"> --> sufficient action of promoting blood circulation can be obtained at a concentration of carbon dioxide gas of 100 ppm or more by using the composition of the present invention. Furthermore, a combination use with a TRPM8 agonist of component (B) and an ester oil of component (C) can improve the persistence of the action of promoting blood circulation and can alleviate symptoms. In other words, the present invention is advantageous from the viewpoint that a sufficient effect can be obtained even at a content of carbon dioxide gas of less than 500 ppm at which it was difficult to obtain a persistent action of promoting blood circulation. It is preferable that the content of carbon dioxide gas is 500 ppm or more from the viewpoint that an immediate and persistent effect of promoting blood circulation, tingling sensation, penetration sensation and effectiveness are felt more strongly. By contrast, the content of carbon dioxide gas of 20,000 ppm or less is preferred in manufacturing from the viewpoint of the solubility of carbon dioxide gas.</p>
<p id="p0027" num="0027">When the viscosity of the body cosmetic is low (1,000 Pa·s or less), the concentration of component (A) in the body cosmetic may be measured at 25°C by using a carbon dioxide gas electrode without diluting the body cosmetic. When the viscosity of the body cosmetic is high (1,000 Pa·s or more), the body cosmetic to be measured is put in a container with a lid containing an alkaline solution and sufficiently immersed therein to be<!-- EPO <DP n="8"> --> trapped in the aqueous solution in the form of a carbonate, and then the solution is made acidic again using an acidic buffer; the concentration of carbon dioxide gas in the solution at a room temperature of 25°C is measured by using a carbon dioxide gas electrode, and then the concentration of carbon dioxide gas in the body cosmetic may be calculated based on the concentration of carbon dioxide gas obtained, the weight of the cosmetic and the volume of the solution.</p>
<p id="p0028" num="0028">The TRPM8 agonist, which is component (B) used in the present invention, acts on TRPM8, a cold receptor of the thermosensitive TRP channels existing in the body.</p>
<p id="p0029" num="0029">The TRPM8 agonist is one or more selected from the group consisting of menthol such as L-menthol and DL-menthol, menthyl lactate, trimethyl isopropyl butanamide, and menthoxypropanediol; plant and essential oil containing TRPM agonist, such as mint oil, peppermint oil, spearmint oil and eucalyptus oil may also be used. These may be used singly or in combinations of two or more. Of them, menthol is preferred from the viewpoint of comfortable feeling and effectiveness upon application.</p>
<p id="p0030" num="0030">The content of component (B), the TRPM8 agonist, is preferably 0.15% by mass or more, more preferably 0.2% by mass or more, further preferably 0.3% by mass or more, still more preferably 0.4% by mass or more based on the total amount of the body cosmetic from the viewpoint of<!-- EPO <DP n="9"> --> increasing the effect of promoting blood circulation, improving the persistence, and obtaining comfortable tingling sensation when using component (A) and component (C) together. Furthermore, the content is preferably 3% by mass or less, more preferably 2% by mass or less, further preferably 1% by mass or less based on the total amount of the body cosmetic from the viewpoint of suppressing skin irritation. The content of component (B) is preferably from 0.15 to 3% by mass, more preferably from 0.2 to 3% by mass, further preferably from 0.3 to 2% by mass, still more preferably from 0.4 to 1% by mass based on the body cosmetic.</p>
<p id="p0031" num="0031">In the present invention, preferably from 0.15 to 3% by mass, more preferably 0.2 to 3% by mass, further preferably from 0.2 to 1% by mass of menthol is included as component (B) based on the total amount of the body cosmetic.</p>
<p id="p0032" num="0032">The ester oil of component (C) used in the present invention is not particularly limited as long as it is used for usual cosmetics. Examples thereof include isononyl isononanoate, isodecyl isononanoate, isotridecyl isononanoate, isopropyl isostearate, isostearyl isostearate, cetyl 2-ethylhexanoate, isopropyl myristate, isocetyl myristate, octyldodecyl myristate, isostearyl myristate, isopropyl palmitate, octyl palmitate, isostearyl palmitate, (caprylic/capric) triglyceride, (2-ethylhexanoic acid) triglyceride, isostearic acid<!-- EPO <DP n="10"> --> cholesteryl ester, neopentyl glycol dicaprate and neopentyl glycol dioctanoate. These may be used singly or in combinations of two or more.</p>
<p id="p0033" num="0033">Of them, a fatty acid ester or a fatty acid glyceride are preferred from the viewpoint of compatibility with components (A) and (B).</p>
<p id="p0034" num="0034">Preferably, examples of the fatty acid ester include isononyl isononanoate, isopropyl isostearate, isostearyl isostearate, cetyl isoctanoate, isopropyl myristate, isostearyl myristate, isopropyl palmitate, octyl palmitate and isostearyl palmitate.</p>
<p id="p0035" num="0035">Examples of the fatty acid glyceride include triglyceride, diglyceride and monoglyceride, and triglyceride is preferred. Fatty acids constituting triglyceride, diglyceride and monoglyceride are not particularly limited. Examples thereof include a saturated fatty acid and an unsaturated fatty acid having 2 to 24 carbon atoms, preferably a saturated fatty acid and an unsaturated fatty acid having 4 to 18 carbon atoms, such as caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, α-linolenic acid and γ-linolenic acid.</p>
<p id="p0036" num="0036">Of them, (caprylic/capric) triglyceride, isononyl isononanoate, isopropyl myristate, isopropyl isostearate and isopropyl palmitate are preferred, (caprylic/capric) triglyceride, isononyl isononanoate and isopropyl<!-- EPO <DP n="11"> --> myristate are more preferred, and (caprylic/capric) triglyceride is further preferred as component (C).</p>
<p id="p0037" num="0037">The content of component (C), ester oil, is 0.01% by mass or more, preferably 0.05% by mass or more, more preferably 0.1% by mass or more; and 3% by mass or less, preferably 1% by mass or less, more preferably 0.5% by mass or less based on the total amount of the body cosmetic from the viewpoint of improving the effect of promoting blood circulation. The content of component (C) is from 0.01 to 3% by mass, preferably from 0.05 to 1% by mass, more preferably from 0.1 to 0.5% by mass based on the total amount of the body cosmetic.</p>
<p id="p0038" num="0038">In the present invention, the mass ratio of component (B) to component (C), (B)/(C), is preferably from 0.5 to 10, more preferably from 1 to 8, further preferably from 2 to 6 from the viewpoint of penetration into the skin.</p>
<p id="p0039" num="0039">The content of component (D), water, is preferably 60% by mass or more, more preferably from 65 to 95% by mass, further preferably from 70 to 90% by mass based on the total amount of the body cosmetic from the viewpoint of including carbon dioxide gas at high concentration.</p>
<p id="p0040" num="0040">It is preferable that the body cosmetic of the present invention does not contain (E) ethanol. Although<!-- EPO <DP n="12"> --> a very small or small amount (0.001% by mass or more) of ethanol may be inevitably mixed, it is preferable that the amount of ethanol is as low as possible even in such cases. This is because there is a concern that ethanol not only causes skin irritation but also facilitates rapid drying of the skin to cause chapped skin, in particular, in people with hypersensitivity to ethanol. More specifically, the content of ethanol is preferably less than 5% by mass, more preferably less than 3% by mass, further preferably less than 1% by mass based on the total amount of the body cosmetic. It is more preferable that the body cosmetic does not contain (E) ethanol. This is preferable because the effect of promoting blood circulation of the body cosmetic can be maintained without increasing skin irritation.</p>
<p id="p0041" num="0041">Other components usually used for cosmetics and drugs may be mixed in the body cosmetic of the present invention in addition to the above components according to the purpose of use, such as an oil component other than those described above, a powder component, a moisturizing agent, a water-soluble polymer, a thickener, a film forming agent, an ultraviolet absorber, a sequestrant, an alcohol, a saccharide, an amino acid derivative, an organic amine, a synthetic resin emulsion, a known blood circulation promoter, a skin nutrient, vitamin, an antioxidant, an auxiliary antioxidant, an antiseptic, a colorant and a fragrance.<!-- EPO <DP n="13"> --></p>
<p id="p0042" num="0042">Fragrances described in various references, e.g., "<nplcit id="ncit0003" npl-type="b"><text>Synthetic Perfume, Chemistry and Knowledge on products" Motoichi Indo, 1996, The Chemical Daily Co., Ltd.</text></nplcit>; "<nplcit id="ncit0004" npl-type="s"><text>Perfume and Flavor Chemicals," STEFFEN ARCTAMDER, 1969</text></nplcit>, are preferably used.</p>
<p id="p0043" num="0043">When applied to the skin, the body cosmetic of the present invention has a viscosity at 25°C of preferably 10 Pa·s or more, more preferably 1,000 Pa·s or more, further preferably from 2,000 to 100,000 Pa·s, still more preferably from 5,000 to 50,000 Pa·s from the viewpoint of convenience and comfortability upon application. The body cosmetic is packed in a container for measurement of viscosity and stored in a thermostat at 25°C for 24 hours, and then the viscosity is measured by using TV-10R type viscometer (VISCOMETER TV-10 made by Toki Sangyo Co., Ltd.) with rotor T-F in the condition of a rotational speed of 1 rpm and a time of 1 minute.</p>
<p id="p0044" num="0044">The body cosmetic of the present invention has a pH of preferably 7.5 or less, more preferably from 4.5 to 7.0 from the viewpoint of exhibiting a good action of promoting blood circulation. The pH of the body cosmetic may be adjusted by using a pH adjuster so that the final pH falls within the above range. For example, an organic acid such as succinic acid, citric acid and tartaric acid,<!-- EPO <DP n="14"> --> a salt thereof, phosphoric acid or a salt thereof is preferably used as the pH adjuster.</p>
<p id="p0045" num="0045">For the pH, when the viscosity is low (1,000 Pa·s or less), the value measured at 25°C of room temperature, without diluting the body cosmetic is determined as the pH of the body cosmetic of the present invention. When the viscosity is high (1,000 Pa·s or more), the value obtained by measurement at a room temperature of 25°C using a liquid component prepared by adding the body cosmetic to water in an amount 10 times the amount of the body cosmetic and sufficiently stirring the mixture, is determined as the pH of the body cosmetic of the present invention.</p>
<p id="p0046" num="0046">For the body cosmetic of the present invention, embodiments which may be adopted include an embodiment in which carbon dioxide gas is dissolved into the body cosmetic immediately before using the cosmetic, an embodiment, so-called disposable type, in which the body cosmetic is sealed in a sealed container such as an aluminum pillow package or an aerosol container so that carbon dioxide gas is previously dissolved into the body cosmetic, or an embodiment in which a carbonate and an acid is reacted to generate carbon dioxide gas so that carbon dioxide gas is dissolved into the body cosmetic.</p>
<p id="p0047" num="0047">The body cosmetic of the present invention is applied to the external skin all over the body. The body<!-- EPO <DP n="15"> --> cosmetic is used in various applications including, in addition to so-called cosmetics, drugs and quasi-drugs. Examples include a facial or body cosmetic such as a sheet-shaped cosmetic, a cream, a lotion and a facial mask, a detergent, a gel, an ointment and a patch. Furthermore, the form of the body cosmetic of the present invention is not particularly limited, and may be a liquid, a lotion, an emulsion, a mist, a foam, a gel or a gel sheet depending on the purpose of use. The body cosmetic is preferably in the form of a foam, a gel or a gel sheet, more preferably a gel sheet from the viewpoint of keeping the body cosmetic on the surface of the skin for a long time so that the active ingredient penetrates the skin well to achieve a sufficient effect of promoting blood circulation.</p>
<p id="p0048" num="0048">For the portion to which the body cosmetic of the present invention is applied, the body cosmetic may be applied to the body excluding scalp, such as the leg, the arm, the shoulder and the waist. Since the body cosmetic of the present invention enables one to feel effectiveness such as tingling sensation and penetration sensation clearly, effectiveness can be felt strongly even in relatively insensitive portions, e.g., the leg including the calf, the ankle and the foot sole, and therefore the body cosmetic of the present invention is useful.<!-- EPO <DP n="16"> --></p>
<p id="p0049" num="0049">Furthermore, since the body cosmetic ensures an excellent effect of promoting blood circulation, the body cosmetic is useful as a body cosmetic for promoting blood circulation.</p>
<p id="p0050" num="0050">The body cosmetic of the present invention is used by directly applying it to the skin other than the scalp. More specifically, the body cosmetic of the present invention is applied to the surface of the skin of the body where symptoms such as fatigue, weariness, swelling and pain are felt.</p>
<p id="p0051" num="0051">It is preferable that at that time, a sufficient amount of the body cosmetic is applied thereto from the viewpoint of obtaining and maintaining the effect of increasing blood flow rate. More specifically, the thickness of the body cosmetic applied to the surface of the skin is preferably 0.5 mm or more, more preferably 0.7 mm or more, further preferably 1 mm or more. The thickness is preferably 3 mm or less, more preferably 2 mm or less.</p>
<p id="p0052" num="0052">It is preferable that when the body cosmetic of the present invention is formed into a gel sheet, the body cosmetic of the present invention is used as a gel layer to form a sheet-shaped body cosmetic having the gel layer. The gel layer has a thickness of preferably 0.5 mm or more, more preferably 0.7 mm or more, further preferably 1 mm or more from the viewpoint of the effect of promoting blood circulation, retainability of carbon<!-- EPO <DP n="17"> --> dioxide gas and easy attachment. The gel layer has a thickness of preferably 3 mm or less, more preferably 2 mm or less from the viewpoint of easy attachment.</p>
<p id="p0053" num="0053">The body cosmetic of the present invention is preferably in the form of a gel sheet from the viewpoint that it can be more easily used.</p>
<p id="p0054" num="0054">When the body cosmetic of the present invention is in the form of a gel sheet, the body cosmetic of the present invention may be produced by a method in which a sheet having a hydrogel layer containing components (B), (C) and (D) is placed in a pillow package and then the gas in the package is replaced with (A) carbon dioxide gas. The body cosmetic may also be produced by a method in which carbon dioxide gas is dissolved into a gel at the time of or after forming a sheet, and the resulting sheet is placed in a pillow package, and then the gas in the package is removed or further replaced with carbon dioxide gas.</p>
<p id="p0055" num="0055">In this case the body cosmetic of the present invention is used as a hydrogel layer.</p>
<p id="p0056" num="0056">When the body cosmetic of the present invention is formed into a hydrogel layer, a body cosmetic sheet in which the hydrogel layer is supported by a sheet substrate may be formed. The hydrogel layer is preferably disposed on the sheet substrate, and more preferably stacked on the sheet substrate. In this body cosmetic sheet, a peeling layer may also be stacked.<!-- EPO <DP n="18"> --></p>
<p id="p0057" num="0057">Any hydrogel layer may be used as long as the layer can retain water in a stable manner. It is preferable that the layer has a cross-linked structure formed from an anionic polymer, a cross-linking agent and water. It is preferable that a water-soluble anionic polymer is dissolved in water and cross-linked to form a hydrogel having a cross-linked structure of an anionic polymer, from the viewpoint of moldability.</p>
<p id="p0058" num="0058">The above cross-linked structure of an anionic polymer forms a dense network structure, which is the basic backbone of the hydrogel layer, by the crosslinking reaction of the anionic polymer, a cross-linking agent and water. The hydrogel layer formed by chemical crosslinking of an anionic polymer retains a large amount of water in the network structure, and is swelled, and thus has moderate elasticity, extensibility and flexibility. Furthermore, the hydrogel formed by chemical crosslinking is less thermoplastic than, for example, agar gel, and thus exhibits stable shape-retainability in a wide range of operating temperature.</p>
<p id="p0059" num="0059">Examples of a water-soluble anionic polymer include a polymer having a carboxyl group, a sulfate group or a phosphate group. Specific examples thereof include poly(meth)acrylic acid, carboxyvinyl polymer and a salt thereof; an anionic cellulose derivative and a salt thereof such as carboxymethylcellulose and<!-- EPO <DP n="19"> --> carboxyethylcellulose; carrageenan, alginic acid and a salt thereof, and an anionic starch derivative. It is preferable that at least one member selected from the group consisting of poly(meth)acrylic acid, carboxymethylcellulose, carrageenan and a salt thereof is included so as to obtain a hydrogel which achieves all of a large amount of water retained, sufficient gel strength and flexibility to follow irregularities and movement of the skin. Furthermore, carboxymethylcellulose, sodium carboxymethylcellulose, polyacrylic acid and sodium polyacrylate are more preferred from the viewpoint that they are industrially available at relatively low cost.</p>
<p id="p0060" num="0060">The content of the anionic polymer is preferably from 0.5 to 25% by mass, more preferably from 3 to 10% by mass based on the hydrogel layer, which is the body cosmetic of the present invention. Furthermore, the content of the anionic polymer is preferably from 0.5 to 6% by mass based on the hydrogel layer when a water-soluble polymer is mixed in order to adjust the viscosity of uncrosslinked gel and increase shape-retainability of cross-linked gel by being physically entangled with the network structure of the anionic polymer.</p>
<p id="p0061" num="0061">A metal ion compound, a cationic polymer or a multifunctional epoxy compound, for example, may be used as the cross-linking agent. The cross-linking agent is<!-- EPO <DP n="20"> --> selected based on the reactivity to the functional group of the anionic polymer to be used.</p>
<p id="p0062" num="0062">Examples of a metal ion compound include an oxide, a hydroxide and a salt containing aluminum, magnesium, calcium, potassium or the like, such as aluminum hydroxide, potassium alum, aluminum sulfate, aluminum oxide, aluminum glycinate, aluminum acetate, aluminum lactate, aluminum stearate, hydrated aluminum silicate, aluminum metasilicate, magnesium aluminometasilicate, magnesium chloride, magnesium stearate, calcium carbonate, calcium hydroxide, kaolin, synthetic hydrotalcite and potassium hydroxide. These may be mixed alone or in combination of two or more.</p>
<p id="p0063" num="0063">When carboxymethylcellulose or a salt thereof is selected as the anionic polymer, an aluminum ion compound such as magnesium aluminometasilicate and magnesium hydroxide is preferably used as a cross-linking agent.</p>
<p id="p0064" num="0064">The content of the cross-linking agent in the hydrogel layer is preferably from 0.01 to 10% by mass, more preferably from 0.05 to 5% by mass, further preferably from 0.1 to 2% by mass in the hydrogel layer.</p>
<p id="p0065" num="0065">Other components usually used for cosmetics and drugs may be mixed in the body cosmetic of the present invention (hydrogel layer) as necessary in addition to components (A) to (D), the anionic polymer and the crosslinking agent.<!-- EPO <DP n="21"> --></p>
<p id="p0066" num="0066">It is preferable that the hydrogel layer has a pH of from 4.5 to 7.0 from the viewpoint of exhibiting a good action of promoting blood circulation.</p>
<p id="p0067" num="0067">The hydrogel layer has a thickness of preferably 0.5 mm or more, more preferably 0.7 mm or more, further preferably 1 mm or more from the viewpoint of the effect of promoting blood circulation, retainability of carbon dioxide gas and easy attachment. The hydrogel layer has a thickness of preferably 3 mm or less, more preferably 2 mm or less from the viewpoint of easy attachment.</p>
<p id="p0068" num="0068">When the hydrogel layer, which is the body cosmetic of the present invention, is formed into a body cosmetic sheet in which the hydrogel layer is supported by a sheet substrate, woven fabric, nonwoven fabric, knitted fabric, synthetic resin film, waterproof paper and the like may be used as the sheet substrate, and a laminate thereof may also be used. More specifically, woven or nonwoven fabric of synthetic fiber such as nylon, polypropylene, polyester, polyethylene, polystyrene, polyurethane and polyolefin, or natural fiber such as silk, cotton, hemp, rayon and collagen; sheet of nylon, polypropylene, polyester, polyethylene, polyurethane and the like; and thin film sheet of pullulan or starch may be used. The sheet substrate has a thickness of about from 0.05 to 2.0 mm. The surface of the sheet substrate may be hydrophilized or hydrophobized.</p>
<p id="p0069" num="0069"><!-- EPO <DP n="22"> --> In the body cosmetic sheet, a peeling layer may also be stacked. The peeling layer (sheet, film) may be stacked on the hydrogel layer on the side opposite to the support (sheet substrate) of the hydrogel layer in order to protect the surface to be attached. Examples of a base material of the peeling layer (sheet, film), which are not particularly limited, include polyester film such as polyethylene terephthalate film and polybutylene terephthalate film; polyolefin film such as polyethylene film and polypropylene film; and laminated paper prepared by laminating plastic such as polyethylene on craft paper, glassine paper, woodfree paper or the like. A peeling layer whose side has been hydrophobized with, for example, silicone, is more preferred. The peeling layer is stacked on the hydrogel with its hydrophobized surface facing the hydrogel.</p>
<p id="p0070" num="0070">More specifically, commercially available products such as Purex (Dupont Teijin Films), Cerapeel MF (Toray Advanced Film Co., Ltd.) and release paper (Lintec Corporation) may be used as the peeling layer.</p>
<p id="p0071" num="0071">It is preferable that the body cosmetic sheet is sealed in a pillow package together with carbon dioxide gas in order to dissolve carbon dioxide gas in a gel and keep carbon dioxide gas being dissolved. At that stage, the amount of carbon dioxide gas is 50% by mass or more, preferably 70% by mass or more, further preferably 95% by mass or more based on the amount of gas in the pillow<!-- EPO <DP n="23"> --> package from the viewpoint of maintaining the concentration of carbon dioxide gas dissolved in the gel.</p>
<p id="p0072" num="0072">When the content includes water, usually not only carbon dioxide gas but also nitrogen gas is used in a mixture; and the concentration of carbon dioxide gas is considered to be preferably from 20 to 30% by mass. The concentration is 70% by mass or less at most although it depends on the type of the content. In the present invention, the gas other than carbon dioxide gas is not particularly limited, and for example, air and nitrogen gas are preferred. The pressure of the gas in the pillow package is preferably from 0.8 to 2.0 atm, more preferably from 0.9 to 1.5 atm, further preferably from 0.9 to 1.2 atm at 25°C.</p>
<p id="p0073" num="0073">The pillow package needs to have poor permeability to carbon dioxide gas. As used herein, "having poor permeability" means a carbon dioxide gas permeability of 50 cc/ m<sup>2</sup>·day atm or less (ASTM D-1434). It is preferable that the pillow package is carbon dioxide gas impermeable. A material having heat sealing properties is preferred. Specific examples thereof include laminate film prepared by laminating aluminum foil, laminate film having aluminum deposited layer, polyvinylidene chloride film and laminate film having a polyvinylidene chloride layer. The form of the pillow package is preferably a flat bag or a gusset.</p>
<p id="p0074" num="0074"><!-- EPO <DP n="24"> --> It is preferable that the pillow package has a volume such that the filling rate is maintained at preferably from 0.5 to 35%, more preferably from 1 to 25% at 25°C based on the volume calculated from its inner surface area. In this regard, conventional gas such as nitrogen gas, which is insoluble in an aqueous solution, has low thermal expansion; when carbon dioxide gas is dissolved in a gel to saturation, carbon dioxide gas is not dissolved and is volatilized with an increase in temperature, causing the spatial volume to be almost doubled in some cases. For this reason, the pillow package preferably has a volume such that the filling rate is maintained at preferably from 1 to 10% at 25°C based on the volume calculated from its inner surface area.</p>
<p id="p0075" num="0075">The body cosmetic sheet produces the effect of promoting blood circulation when used by being attached to the body.</p>
<p id="p0076" num="0076">The calf, ankle, foot sole, shoulder, waist and arm, for example, are preferred as the portion of the body to which the body cosmetic sheet is applied. The time of use by attaching is not particularly limited, and is preferably 15 minutes or more, more preferably 30 minutes or more. For example, the sheet may be attached before sleep and continuously used during sleep.</p>
<p id="p0077" num="0077"><!-- EPO <DP n="25"> --> For the embodiments described above, the present description also discloses the following compositions and the like.
<ol id="ol0002" compact="compact" ol-style="">
<li>&lt;1&gt; A sheet-shaped body cosmetic comprising the following components (A), (B), (C), and (D):
<ol id="ol0003" compact="compact" ol-style="">
<li>(A) from 100 to 20,000 ppm of carbon dioxide gas,</li>
<li>(B) a TRPM8 agonist being one or more selected from the group consisting of menthol, menthyl lactate, trimethyl isopropyl butanamide, and menthoxypropanediol,</li>
<li>(C) an ester oil, and</li>
<li>(D) water.</li>
</ol></li>
<li>&lt;2&gt; The sheet-shaped body cosmetic according to &lt;1&gt; above, wherein the mass ratio of component (B) to component (C), (B)/(C), is from 0.5 to 10.</li>
<li>&lt;3&gt; The sheet-shaped body cosmetic according to &lt;1&gt; above, wherein the mass ratio of component (B) to component (C), (B)/(C), is from 2 to 6.</li>
<li>&lt;4&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;3&gt; above, wherein component (C) is one or more selected from the group consisting of a fatty acid ester, a fatty acid triglyceride, a fatty acid diglyceride and a fatty acid monoglyceride.</li>
<li>&lt;5&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;4&gt; above, wherein component (C) is (caprylic/capric) triglyceride.<!-- EPO <DP n="26"> --></li>
<li>&lt;6&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;5&gt; above, wherein the content of component (D) is 60% by mass or more.</li>
<li>&lt;7&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;6&gt; above, wherein the sheet-shaped cosmetic comprises a gel layer.</li>
<li>&lt;8&gt; The sheet-shaped body cosmetic according to &lt;7&gt; above, wherein the gel layer has a thickness of 0.7 mm or more.</li>
<li>&lt;9&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;8&gt; above, wherein the content of component (B) is from 0.15 to 3% by mass.</li>
<li>&lt;10&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;8&gt; above, wherein the content of component (B) is from 0.2 to 3% by mass.</li>
<li>&lt;11&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;8&gt; above, wherein component (B) is menthol and the content thereof is from 0.15 to 3% by mass.</li>
<li>&lt;12&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;8&gt; above, wherein component (B) is menthol and the content thereof is from 0.2 to 3% by mass.</li>
<li>&lt;13&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;8&gt; above, wherein component (B) is menthol and the content thereof is from 0.2 to 1% by mass.</li>
<li>&lt;14&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;13&gt; above, wherein the content of ethanol is less than 5% by mass.<!-- EPO <DP n="27"> --></li>
<li>&lt;15&gt; The sheet-shaped body cosmetic according to any one of &lt;7&gt; to &lt;14&gt; above, wherein the gel layer is a hydrogel layer comprising a cross-linked structure formed from an anionic polymer, a cross-linking agent and water.</li>
<li>&lt;16&gt; The sheet-shaped body cosmetic according to any one of &lt;7&gt; to &lt;15&gt; above, wherein the gel layer has a pH of from 4.5 to 7.0.</li>
<li>&lt;17&gt; The sheet-shaped body cosmetic according to any one of &lt;7&gt; to &lt;16&gt; above, wherein the gel layer is stacked on a sheet substrate.</li>
<li>&lt;18&gt; The sheet-shaped body cosmetic according to &lt;17&gt; above, wherein the sheet substrate is selected from the group consisting of woven fabric, nonwoven fabric, knitted fabric, synthetic resin film and waterproof paper.</li>
<li>&lt;19&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;18&gt; above, wherein the sheet-shaped body cosmetic comprises from 100 to 500 ppm of carbon dioxide gas of component (A).</li>
<li>&lt;20&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;19&gt; above, wherein the sheet-shaped body cosmetic comprises from 500 to 20,000 ppm of carbon dioxide gas of component (A).</li>
<li>&lt;21&gt; The sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;20&gt; above, wherein the content of component (C) is from 0.01 to 3% by mass.</li>
<li><!-- EPO <DP n="28"> --> &lt;22&gt; A sheet-shaped body cosmetic comprising the following components (A), (B), (C) and (D):
<ol id="ol0004" compact="compact" ol-style="">
<li>(A) from 100 to 20,000 ppm of carbon dioxide gas,</li>
<li>(B) from 0.15 to 3% by mass of menthol,</li>
<li>(C) from 0.01 to 3% by mass of a fatty acid glyceride, and</li>
<li>(D) water,</li>
</ol>
wherein the mass ratio of component (B) to component (C), (B)/(C), is from 0.5 to 10, and the sheet-shaped body cosmetic comprises a hydrogel layer having a thickness of 0.7 mm or more and 3 mm or less.</li>
<li>&lt;23&gt; A sheet-shaped body cosmetic comprising the following components (A), (B), (C), and (D):
<ol id="ol0005" compact="compact" ol-style="">
<li>(A) from 100 to 20,000 ppm of carbon dioxide gas,</li>
<li>(B) from 0.2 to 3% by mass of menthol,</li>
<li>(C) from 0.01 to 3% by mass of a fatty acid glyceride, and</li>
<li>(D) water,</li>
</ol>
wherein the mass ratio of component (B) to component (C), (B)/(C), is from 0.5 to 10, and the sheet-shaped body cosmetic comprises a hydrogel layer having a thickness of 0.7 mm or more and 3 mm or less.</li>
<li>&lt;24&gt; A sheet-shaped body cosmetic comprising the following components (A), (B), (C) and (D):
<ol id="ol0006" compact="compact" ol-style="">
<li>(A) from 100 to 20,000 ppm of carbon dioxide gas,</li>
<li>(B) from 0.2 to 3% by mass of menthol,<!-- EPO <DP n="29"> --></li>
<li>(C) from 0.01 to 3% by mass of one or more selected from the group consisting of a fatty acid ester, a fatty acid triglyceride, a fatty acid diglyceride and a fatty acid monoglyceride, and</li>
<li>(D) water,</li>
</ol>
wherein the mass ratio of component (B) to component (C), (B)/(C), is from 0.5 to 10, and the sheet-shaped body cosmetic comprises a hydrogel layer having a thickness of 0.7 mm or more and 3 mm or less.</li>
<li>&lt;25&gt; A sheet-shaped body cosmetic comprising the following components (A), (B), (C) and (D):
<ol id="ol0007" compact="compact" ol-style="">
<li>(A) from 100 to 20,000 ppm of carbon dioxide gas,</li>
<li>(B) from 0.2 to 3% by mass of menthol,</li>
<li>(C) from 0.01 to 3% by mass of a fatty acid ester, and</li>
<li>(D) water,</li>
</ol>
wherein the mass ratio of component (B) to component (C), (B)/(C), is from 0.5 to 10, and the sheet-shaped body cosmetic comprises a hydrogel layer having a thickness of 0.7 mm or more and 3 mm or less.</li>
<li>&lt;26&gt; The sheet-shaped body cosmetic according to any one of &lt;22&gt; to &lt;25&gt; above, wherein the mass ratio of component (B) to component (C), (B)/(C), is from 2 to 6.</li>
<li>&lt;27&gt; The sheet-shaped body cosmetic according to any one of &lt;22&gt; to &lt;26&gt; above, wherein the sheet-shaped body<!-- EPO <DP n="30"> --> cosmetic comprises from 500 to 20,000 ppm of carbon dioxide gas of component (A).</li>
<li>&lt;28&gt; The sheet-shaped body cosmetic according to any one of &lt;22&gt; to &lt;27&gt; above, wherein the hydrogel layer is stacked on a sheet substrate.</li>
<li>&lt;29&gt; Use of the sheet-shaped body cosmetic according to any one of &lt;1&gt; to &lt;28&gt; above for promoting blood circulation, wherein the sheet-shaped body cosmetic is applied to any one of the calf, the ankle, the foot sole, the shoulder, the waist and the arm.</li>
</ol></p>
<heading id="h0006">Examples</heading>
<p id="p0078" num="0078">In the following, the present invention will be described in more detail with reference to Examples. The present invention is not limited to these Examples.</p>
<p id="p0079" num="0079">Examples 1 to 7, Comparative Examples 1 to 2<br/>
A body cosmetic (gel sheet) was produced according to the formulation shown in Table 1 and evaluated for the rate of increase in blood flow, comfortability, tingling sensation, penetration sensation and skin irritation. The results are shown in Table 1. Furthermore, the results for the rate of increase in blood flow in Example 1 and Comparative Example 1 are shown in <figref idref="f0001">Figure 1</figref>.</p>
<p id="p0080" num="0080">The tingling sensation means a comfortable sensation of increased blood circulation at the portion of<!-- EPO <DP n="31"> --> application. The penetration sensation means a sensation of deep penetration of components into the portion of application with a comfortable sensation of increased blood circulation in a deeper portion.</p>
<heading id="h0007">(Method of production)</heading>
<p id="p0081" num="0081">After preparing a raw liquid of uncrosslinked hydrogel according to the formulation shown in Table 1, a gel sheet was prepared. More specifically, carboxymethylcellulose, polyvinyl alcohol, dried aluminum hydroxide gel, glycerin and methyl paraoxybenzoate were mixed with an aqueous succinic acid solution, and the mixture was introduced into a kneader. Then, propylene glycol in which a TRPM8 agonist had been dissolved by heating was added thereto and the mixture was mixed to prepare an uncrosslinked gel. The uncrosslinked gel obtained was sandwiched between polyethylene film and non-woven fabric, and the resultant was spread by a Baker type applicator so that the thickness of the hydrogel was 1 mm. Furthermore, the same was aged at 50°C for 2 days to facilitate ion cross-linking reaction of the hydrogel to give a cross-linked gel sheet. The gel sheet obtained was punched into a square (area 25 cm<sup>2</sup>) and inserted into an aluminum pillow package. The pillow package was sealed after replacing 90% or more of the air in the pillow package with carbon dioxide gas to set the concentration of carbon dioxide gas in the gel at about 1,000 ppm. The same was kept for 5 days and used as a<!-- EPO <DP n="32"> --> gel sheet for evaluation. The aluminum pillow package was opened upon application and the gel sheet for evaluation was immediately attached to the skin. The action of increasing blood flow in the inner forearm and the sensation when the sheet was attached to the calf were evaluated based on the following criteria. In Example 7, the sheet was left in the air for about 1 minute after opening to adjust the concentration of carbon dioxide gas to about 250 ppm. The pH of the gel sheets for evaluation was from 4.5 to 7.0.</p>
<heading id="h0008">(Method of evaluation)</heading>
<heading id="h0009">(1) Rate of increase in blood flow:</heading>
<p id="p0082" num="0082">After acclimation at a room temperature of about 25 ± 1°C and a humidity of about 50 ± 5% for 20 minutes, the blood flow in the inner forearm was measured by a laser speckle blood flow meter and determined as a value before application. The blood flow was measured 5 minutes, 30 minutes and 60 minutes after attaching each gel sheet to the inner forearm, and the rate of increase (%) was calculated based on the blood flow rate before application, which was taken as 100.</p>
<heading id="h0010">(2) Comfortability</heading>
<p id="p0083" num="0083">Comfortability was evaluated by three expert panelists 5 minutes, 30 minutes and 60 minutes after each gel sheet was attached to the calf based on the following<!-- EPO <DP n="33"> --> criteria. The results are shown in an average value of the three panelists.
<dl id="dl0001" compact="compact">
<dt>7:</dt><dd>Very comfortable</dd>
<dt>6:</dt><dd>Comfortable</dd>
<dt>5:</dt><dd>Relatively comfortable</dd>
<dt>4:</dt><dd>Moderate</dd>
<dt>3:</dt><dd>Relatively unpleasant</dd>
<dt>2:</dt><dd>Unpleasant</dd>
<dt>1:</dt><dd>Very unpleasant</dd>
</dl></p>
<heading id="h0011">(3) Tingling sensation, penetration sensation</heading>
<p id="p0084" num="0084">Coolness, tingling sensation, and penetration sensation were evaluated by three expert panelists 5 minutes, 30 minutes and 60 minutes after each gel sheet was attached to the calf based on the following criteria. The results are shown in an average value of the three panelists.
<dl id="dl0002" compact="compact">
<dt>7:</dt><dd>Very strongly felt</dd>
<dt>6:</dt><dd>Strongly felt</dd>
<dt>5:</dt><dd>Relatively strongly felt</dd>
<dt>4:</dt><dd>Clearly felt</dd>
<dt>3:</dt><dd>Felt</dd>
<dt>2:</dt><dd>Slightly felt</dd>
<dt>1:</dt><dd>Not felt at all</dd>
</dl></p>
<heading id="h0012">(4) Skin irritation:</heading><!-- EPO <DP n="34"> -->
<p id="p0085" num="0085">Skin irritation when each gel sheet was attached to the calf was evaluated by expert panelists based on the following criteria.
<ol id="ol0008" compact="compact" ol-style="">
<li>a: No irritation felt</li>
<li>b: Irritation slightly felt</li>
<li>c: Irritation felt</li>
</ol><!-- EPO <DP n="35"> -->
<tables id="tabl0001" num="0001">
<table frame="all">
<title>[Table 1]</title>
<tgroup cols="12">
<colspec colnum="1" colname="col1" colwidth="10mm"/>
<colspec colnum="2" colname="col2" colwidth="31mm"/>
<colspec colnum="3" colname="col3" colwidth="23mm"/>
<colspec colnum="4" colname="col4" colwidth="28mm"/>
<colspec colnum="5" colname="col5" colwidth="18mm"/>
<colspec colnum="6" colname="col6" colwidth="18mm"/>
<colspec colnum="7" colname="col7" colwidth="18mm"/>
<colspec colnum="8" colname="col8" colwidth="18mm"/>
<colspec colnum="9" colname="col9" colwidth="18mm"/>
<colspec colnum="10" colname="col10" colwidth="18mm"/>
<colspec colnum="11" colname="col11" colwidth="18mm"/>
<colspec colnum="12" colname="col12" colwidth="28mm"/>
<thead>
<row>
<entry colsep="0" align="center" valign="middle"/>
<entry namest="col2" nameend="col3" align="center" valign="middle">Component mixed</entry>
<entry align="center" valign="middle">Comparative Example 1</entry>
<entry align="center" valign="middle">Example 1</entry>
<entry align="center" valign="middle">Example 2</entry>
<entry align="center" valign="middle">Example 3</entry>
<entry align="center" valign="middle">Example 4</entry>
<entry align="center" valign="middle">Example 5</entry>
<entry align="center" valign="middle">Example 6</entry>
<entry align="center" valign="middle">Example 7</entry>
<entry align="center" valign="middle">Comparative Example 2</entry></row></thead>
<tbody>
<row>
<entry morerows="6" align="center"/>
<entry namest="col2" nameend="col3" align="left">Carboxymethylcellulose</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry>
<entry align="center">3.5</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">Polyvinyl alcohol</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry>
<entry align="center">3</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">Dried aluminum hydroxide</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry>
<entry align="center">0.15</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">Succinic acid</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">Methyl paraoxybenzoate</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry>
<entry align="center">0.25</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">Glycerin</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">Propylene glycol</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry>
<entry align="center">5</entry></row>
<row>
<entry morerows="1" align="center" valign="bottom">(B)</entry>
<entry namest="col2" nameend="col3" align="left">Menthol</entry>
<entry align="center"/>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center"/>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry>
<entry align="center">0.4</entry></row>
<row>
<entry namest="col2" nameend="col3" align="left">N,2,3-trimethyl-2-isopropyl butanamide</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center">2</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/></row>
<row>
<entry morerows="2" align="center" valign="middle">(C)</entry>
<entry namest="col2" nameend="col3" align="left">(Caprylic/ capric) triglyceride</entry>
<entry align="center">0.1</entry>
<entry align="center">0.1</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center">0.5</entry>
<entry align="center">0.05</entry>
<entry align="center">0.4</entry>
<entry align="center">0.1</entry>
<entry align="center"/></row>
<row>
<entry namest="col2" nameend="col3" align="left">Isononyl isononanoate</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center">0.1</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/></row>
<row>
<entry namest="col2" nameend="col3" align="left">Isopropyl myristate</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center">0.1</entry>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/>
<entry align="center"/></row>
<row>
<entry align="center">(D)</entry>
<entry namest="col2" nameend="col3" align="left">Purified water</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry>
<entry align="center">Balance</entry></row>
<row>
<entry colsep="0" align="center"/>
<entry namest="col2" nameend="col3" align="left">Total</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry>
<entry align="center">100</entry></row>
<row>
<entry align="center">(A)</entry>
<entry namest="col2" nameend="col3" align="left">Concentration of carbon dioxide gas (ppm)</entry>
<entry align="center">1000</entry>
<entry align="center">1000</entry>
<entry align="center">1000</entry>
<entry align="center">1000</entry>
<entry align="center">1000</entry>
<entry align="center">1000</entry>
<entry align="center">1000</entry>
<entry align="center">250</entry>
<entry align="center">250</entry></row>
<row>
<entry colsep="0" align="center"/>
<entry namest="col2" nameend="col3" align="left">(B)/(C)</entry>
<entry align="center">-</entry>
<entry align="center">4.0</entry>
<entry align="center">4.0</entry>
<entry align="center">4.0</entry>
<entry align="center">4.0</entry>
<entry align="center">8.0</entry>
<entry align="center">1.0</entry>
<entry align="center">4.0</entry>
<entry align="center">-</entry></row>
<row>
<entry morerows="2" colsep="0" align="center"/>
<entry morerows="2" valign="middle">Rate of increase in blood flow (%)</entry>
<entry align="center">After 5 minutes</entry>
<entry align="center">148</entry>
<entry align="center">179</entry>
<entry align="center">153</entry>
<entry align="center">136</entry>
<entry align="center">183</entry>
<entry align="center">136</entry>
<entry align="center">143</entry>
<entry align="center">165</entry>
<entry align="center">109</entry></row>
<row>
<entry align="center">After 30 minutes</entry>
<entry align="center">93</entry>
<entry align="center">126</entry>
<entry align="center">148</entry>
<entry align="center">169</entry>
<entry align="center">153</entry>
<entry align="center">153</entry>
<entry align="center">117</entry>
<entry align="center">119</entry>
<entry align="center">128</entry></row>
<row>
<entry align="center">After 60 minutes</entry>
<entry align="center">82</entry>
<entry align="center">180</entry>
<entry align="center">148</entry>
<entry align="center">177</entry>
<entry align="center">154</entry>
<entry align="center">185</entry>
<entry align="center">133</entry>
<entry align="center">172</entry>
<entry align="center">128</entry></row>
<row>
<entry morerows="2" colsep="0" align="center"/>
<entry morerows="2" valign="middle">Comfortability</entry>
<entry align="center">After 5 minutes</entry>
<entry align="center">4.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">4.7</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry></row>
<row>
<entry align="center">After 30 minutes</entry>
<entry align="center">4.0</entry>
<entry align="center">6.3</entry>
<entry align="center">6.3</entry>
<entry align="center">6.3</entry>
<entry align="center">5.3</entry>
<entry align="center">6.3</entry>
<entry align="center">6.3</entry>
<entry align="center">6.0</entry>
<entry align="center">6.0</entry></row>
<row>
<entry align="center">After 60 minutes</entry>
<entry align="center">4.0</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">6.0</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry>
<entry align="center">5.3</entry></row>
<row>
<entry morerows="2" colsep="0" align="center"/>
<entry morerows="2" valign="middle">Tingling sensation</entry>
<entry align="center">After 5 minutes</entry>
<entry align="center">1.0</entry>
<entry align="center">2.0</entry>
<entry align="center">1.7</entry>
<entry align="center">1.3</entry>
<entry align="center">1.3</entry>
<entry align="center">1.7</entry>
<entry align="center">1.7</entry>
<entry align="center">2.0</entry>
<entry align="center">1.0</entry></row>
<row>
<entry align="center">After 30 minutes</entry>
<entry align="center">1.0</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">4.7</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">3.3</entry>
<entry align="center">3.3</entry></row>
<row>
<entry align="center">After 60 minutes</entry>
<entry align="center">1.0</entry>
<entry align="center">3.7</entry>
<entry align="center">3.3</entry>
<entry align="center">3.3</entry>
<entry align="center">4.0</entry>
<entry align="center">3.7</entry>
<entry align="center">3.3</entry>
<entry align="center">3.7</entry>
<entry align="center">3.0</entry></row>
<row>
<entry morerows="2" colsep="0" align="center"/>
<entry morerows="2" valign="middle">Penetration sensation</entry>
<entry align="center">After 5 minutes</entry>
<entry align="center">1.0</entry>
<entry align="center">1.7</entry>
<entry align="center">1.7</entry>
<entry align="center">1.7</entry>
<entry align="center">1.3</entry>
<entry align="center">1.7</entry>
<entry align="center">1.7</entry>
<entry align="center">1.7</entry>
<entry align="center">1.0</entry></row>
<row>
<entry align="center">After 30 minutes</entry>
<entry align="center">1.0</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">4.3</entry>
<entry align="center">3.7</entry>
<entry align="center">3.3</entry></row>
<row>
<entry align="center">After 60 minutes</entry>
<entry align="center">1.0</entry>
<entry align="center">2.3</entry>
<entry align="center">2.0</entry>
<entry align="center">2.0</entry>
<entry align="center">4.3</entry>
<entry align="center">2.3</entry>
<entry align="center">2.3</entry>
<entry align="center">2.3</entry>
<entry align="center">2.0</entry></row>
<row>
<entry colsep="0" align="center"/>
<entry namest="col2" nameend="col3" align="center">Skin irritation</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry>
<entry align="center">a</entry></row></tbody></tgroup>
</table>
</tables></p>
</description>
<claims id="claims01" lang="en"><!-- EPO <DP n="36"> -->
<claim id="c-en-01-0001" num="0001">
<claim-text>A sheet-shaped body cosmetic comprising the following components (A), (B), (C), and (D):
<claim-text>(A) from 100 to 20,000 ppm of carbon dioxide gas,</claim-text>
<claim-text>(B) a TRPM8 agonist being one or more selected from the group consisting of menthol, menthyl lactate, trimethyl isopropyl butanamide, and menthoxypropanediol,</claim-text>
<claim-text>(C) 0.01 to 3% by mass of an ester oil, and</claim-text>
<claim-text>(D) water.</claim-text></claim-text></claim>
<claim id="c-en-01-0002" num="0002">
<claim-text>The sheet-shaped body cosmetic according to claim 1, wherein the mass ratio of the component (B) to the component (C), (B)/(C), is from 0.5 to 10.</claim-text></claim>
<claim id="c-en-01-0003" num="0003">
<claim-text>The sheet-shaped body cosmetic according to claim 1 or 2, wherein the component (C) is one or more selected from the group consisting of a fatty acid ester, a fatty acid triglyceride, a fatty acid diglyceride and a fatty acid monoglyceride.</claim-text></claim>
<claim id="c-en-01-0004" num="0004">
<claim-text>The sheet-shaped body cosmetic according to any one of claims 1 to 3, wherein the component (C) is (caprylic/capric) triglyceride.</claim-text></claim>
<claim id="c-en-01-0005" num="0005">
<claim-text><!-- EPO <DP n="37"> --> The sheet-shaped body cosmetic according to any one of claims 1 to 4, wherein the content of the component (B) is from 0.15% by mass to 3% by mass.</claim-text></claim>
<claim id="c-en-01-0006" num="0006">
<claim-text>The sheet-shaped body cosmetic according to any one of claims 1 to 5, wherein the content of the component (D) is 60% by mass or more.</claim-text></claim>
<claim id="c-en-01-0007" num="0007">
<claim-text>The sheet-shaped body cosmetic according to any one of claims 1 to 6, wherein the component (B) is menthol and the content thereof is from 0.2 to 1% by mass.</claim-text></claim>
<claim id="c-en-01-0008" num="0008">
<claim-text>The sheet-shaped body cosmetic according to any one of claims 1 to 7, wherein the content of ethanol is less than 5% by mass.</claim-text></claim>
<claim id="c-en-01-0009" num="0009">
<claim-text>The sheet-shaped body cosmetic according to any one of claims 1 to 8, wherein the sheet-shaped cosmetic comprises a gel layer.</claim-text></claim>
<claim id="c-en-01-0010" num="0010">
<claim-text>The sheet-shaped body cosmetic according to claim 9, wherein the gel layer has a thickness of 0.7 mm or more.</claim-text></claim>
<claim id="c-en-01-0011" num="0011">
<claim-text>The sheet-shaped body cosmetic according to claim 9 or 10, wherein the gel layer is a hydrogel layer comprising a cross-linked structure formed from an anionic polymer, a cross-linking agent and water.</claim-text></claim>
<claim id="c-en-01-0012" num="0012">
<claim-text><!-- EPO <DP n="38"> --> The sheet-shaped body cosmetic according to any one of claims 1 to 11, wherein the sheet-shaped body cosmetic further comprises a peeling layer.</claim-text></claim>
<claim id="c-en-01-0013" num="0013">
<claim-text>The sheet-shaped body cosmetic according to any one of claims 1 to 12, wherein the body cosmetic sheet is sealed in a pillow package together with carbon dioxide gas.</claim-text></claim>
<claim id="c-en-01-0014" num="0014">
<claim-text>Use of the sheet-shaped body cosmetic according to any one of claims 1 to 13 for promoting blood circulation of any one of the calf, the ankle, the foot sole, the shoulder, the waist and the arm.</claim-text></claim>
</claims>
<claims id="claims02" lang="de"><!-- EPO <DP n="39"> -->
<claim id="c-de-01-0001" num="0001">
<claim-text>Blattförmiges Körperkosmetikum, umfassend die folgenden Komponenten (A), (B), (C) und (D):
<claim-text>(A) 100 bis 20.000 ppm Kohlendioxidgas,</claim-text>
<claim-text>(B) einen TRPM8-Agonisten, der einer oder mehrere ausgewählt aus der Gruppe bestehend aus Menthol, Menthyllactat, Trimethylisopropylbutanamid und Menthoxypropandiol ist,</claim-text>
<claim-text>(C) 0,01 bis 3 Massen-% eines Esteröls und</claim-text>
<claim-text>(D) Wasser.</claim-text></claim-text></claim>
<claim id="c-de-01-0002" num="0002">
<claim-text>Blattförmiges Körperkosmetikum gemäß Anspruch 1, wobei das Massenverhältnis der Komponente (B) zur Komponente (C), (B)/(C), 0,5 bis 10 beträgt.</claim-text></claim>
<claim id="c-de-01-0003" num="0003">
<claim-text>Blattförmiges Körperkosmetikum gemäß Anspruch 1 oder 2, wobei die Komponente (C) eine oder mehrere ausgewählt aus der Gruppe bestehend aus einem Fettsäureester, einem Fettsäuretriglycerid, einem Fettsäurediglycerid und einem Fettsäuremonoglycerid ist.</claim-text></claim>
<claim id="c-de-01-0004" num="0004">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 3, wobei die Komponente (C) ein Capryltriglycerid/Caprintriglycerid ist.</claim-text></claim>
<claim id="c-de-01-0005" num="0005">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 4, wobei der Gehalt der Komponente (B) 0,15 Massen-% bis 3 Massen-% beträgt.</claim-text></claim>
<claim id="c-de-01-0006" num="0006">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 5, wobei der Gehalt der Komponente (D) 60 Massen-% oder mehr beträgt.<!-- EPO <DP n="40"> --></claim-text></claim>
<claim id="c-de-01-0007" num="0007">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 6, wobei die Komponente (B) Menthol ist und der Gehalt davon 0,2 bis 1 Massen-% beträgt.</claim-text></claim>
<claim id="c-de-01-0008" num="0008">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 7, wobei der Gehalt an Ethanol weniger als 5 Massen-% beträgt.</claim-text></claim>
<claim id="c-de-01-0009" num="0009">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 8, wobei das blattförmige Kosmetikum eine Gelschicht umfasst.</claim-text></claim>
<claim id="c-de-01-0010" num="0010">
<claim-text>Blattförmiges Körperkosmetikum gemäß Anspruch 9, wobei die Gelschicht eine Dicke von 0,7 mm oder mehr aufweist.</claim-text></claim>
<claim id="c-de-01-0011" num="0011">
<claim-text>Blattförmiges Körperkosmetikum gemäß Anspruch 9 oder 10, wobei die Gelschicht eine Hydrogelschicht ist, umfassend eine vernetzte Struktur, die aus einem anionischen Polymer, einem Vernetzungsmittel und Wasser gebildet ist.</claim-text></claim>
<claim id="c-de-01-0012" num="0012">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 11, wobei das blattförmige Körperkosmetikum ferner eine Abziehschicht umfasst.</claim-text></claim>
<claim id="c-de-01-0013" num="0013">
<claim-text>Blattförmiges Körperkosmetikum gemäß mindestens einem der Ansprüche 1 bis 12, wobei das Körperkosmetikblatt in einer Kissenverpackung zusammen mit Kohlendioxidgas versiegelt ist.</claim-text></claim>
<claim id="c-de-01-0014" num="0014">
<claim-text>Verwendung des blattförmigen Körperkosmetikums gemäß mindestens einem der Ansprüche 1 bis 13 zur Förderung der Durchblutung der Wade, des Knöchels, der Fußsohle, der Schulter, der Taille oder des Arms.</claim-text></claim>
</claims>
<claims id="claims03" lang="fr"><!-- EPO <DP n="41"> -->
<claim id="c-fr-01-0001" num="0001">
<claim-text>Produit cosmétique pour le corps en forme de feuille comprenant les composants (A), (B), (C), et (D) suivants :
<claim-text>(A) de 100 à 20 000 ppm de dioxyde de carbone gazeux,</claim-text>
<claim-text>(B) un agoniste de TRPM8 étant un ou plusieurs éléments choisis parmi le groupe consistant en menthol, lactate de menthyle, triméthylisopropylbutanamide, et menthoxypropanediol,</claim-text>
<claim-text>(C) de 0,01 à 3 % en masse d'une huile d'ester, et</claim-text>
<claim-text>(D) de l'eau.</claim-text></claim-text></claim>
<claim id="c-fr-01-0002" num="0002">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon la revendication 1, dans lequel le rapport massique du composant (B) au composant (C), (B)/(C), va de 0,5 à 10.</claim-text></claim>
<claim id="c-fr-01-0003" num="0003">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon la revendication 1 ou 2, dans lequel le composant (C) est un ou plusieurs éléments choisis parmi le groupe consistant en un ester d'acide gras, un triglycéride d'acide gras, un diglycéride d'acide gras et un monoglycéride d'acide gras.</claim-text></claim>
<claim id="c-fr-01-0004" num="0004">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 3, dans lequel le composant (C) est un triglycéride (caprylique/caprique).</claim-text></claim>
<claim id="c-fr-01-0005" num="0005">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 4, dans lequel la teneur du composant (B) va de 0,15 % en masse à 3 % en masse.</claim-text></claim>
<claim id="c-fr-01-0006" num="0006">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 5, dans lequel la teneur du composant (D) est supérieur ou égal à 60 % en masse.<!-- EPO <DP n="42"> --></claim-text></claim>
<claim id="c-fr-01-0007" num="0007">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 6, dans lequel le composant (B) est du menthol et la teneur de celui-ci va de 0,2 à 1 % en masse.</claim-text></claim>
<claim id="c-fr-01-0008" num="0008">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 7, dans lequel la teneur d'éthanol est inférieure à 5 % en masse.</claim-text></claim>
<claim id="c-fr-01-0009" num="0009">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 8, dans lequel le produit cosmétique en forme de feuille comprend une couche de gel.</claim-text></claim>
<claim id="c-fr-01-0010" num="0010">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon la revendication 9, dans lequel la couche de gel présente une épaisseur supérieure ou égale à 0,7 mm.</claim-text></claim>
<claim id="c-fr-01-0011" num="0011">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon la revendication 9 ou 10, dans lequel la couche de gel est une couche d'hydrogel comprenant une structure réticulée formée d'un polymère anionique, d'un agent réticulé et d'eau.</claim-text></claim>
<claim id="c-fr-01-0012" num="0012">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 11, dans lequel le produit cosmétique pour le corps en forme de feuille comprend en outre une couche à décoller.</claim-text></claim>
<claim id="c-fr-01-0013" num="0013">
<claim-text>Produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 12, dans lequel la feuille de produit cosmétique pour le corps est scellée dans un emballage de type coussin avec du dioxyde de carbone gazeux.</claim-text></claim>
<claim id="c-fr-01-0014" num="0014">
<claim-text>Utilisation du produit cosmétique pour le corps en forme de feuille selon l'une quelconque des revendications 1 à 13 pour stimuler la circulation sanguine de l'une quelconque des parties du corps parmi le mollet, la cheville, la plante du pied, l'épaule, la hanche et le bras.</claim-text></claim>
</claims>
<drawings id="draw" lang="en"><!-- EPO <DP n="43"> -->
<figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="139" he="91" img-content="drawing" img-format="tif"/></figure>
</drawings>
<ep-reference-list id="ref-list">
<heading id="ref-h0001"><b>REFERENCES CITED IN THE DESCRIPTION</b></heading>
<p id="ref-p0001" num=""><i>This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.</i></p>
<heading id="ref-h0002"><b>Patent documents cited in the description</b></heading>
<p id="ref-p0002" num="">
<ul id="ref-ul0001" list-style="bullet">
<li><patcit id="ref-pcit0001" dnum="JP2005314298A"><document-id><country>JP</country><doc-number>2005314298</doc-number><kind>A</kind></document-id></patcit><crossref idref="pcit0001">[0010]</crossref></li>
<li><patcit id="ref-pcit0002" dnum="JP2005002046A"><document-id><country>JP</country><doc-number>2005002046</doc-number><kind>A</kind></document-id></patcit><crossref idref="pcit0002">[0010]</crossref></li>
<li><patcit id="ref-pcit0003" dnum="JP2012167061A"><document-id><country>JP</country><doc-number>2012167061</doc-number><kind>A</kind></document-id></patcit><crossref idref="pcit0003">[0010]</crossref></li>
<li><patcit id="ref-pcit0004" dnum="WO2013031031A1"><document-id><country>WO</country><doc-number>2013031031</doc-number><kind>A1</kind></document-id></patcit><crossref idref="pcit0004">[0010]</crossref></li>
<li><patcit id="ref-pcit0005" dnum="JP2016138064A"><document-id><country>JP</country><doc-number>2016138064</doc-number><kind>A</kind></document-id></patcit><crossref idref="pcit0005">[0010]</crossref></li>
</ul></p>
<heading id="ref-h0003"><b>Non-patent literature cited in the description</b></heading>
<p id="ref-p0003" num="">
<ul id="ref-ul0002" list-style="bullet">
<li><nplcit id="ref-ncit0001" npl-type="s"><article><atl/><serial><sertitle>Microvascular Research</sertitle><pubdate><sdate>20160000</sdate><edate/></pubdate><vid>107</vid></serial><location><pp><ppf>39</ppf><ppl>45</ppl></pp></location></article></nplcit><crossref idref="ncit0001">[0011]</crossref></li>
<li><nplcit id="ref-ncit0002" npl-type="s"><article><author><name>CRAIGHEAD DANIEL H et al.</name></author><atl/><serial><sertitle>Mechanisms and time course of menthol-induced cutaneous vasodilation</sertitle><pubdate><sdate>20160000</sdate><edate/></pubdate><vid>110</vid></serial><location><pp><ppf>43</ppf><ppl>47</ppl></pp></location></article></nplcit><crossref idref="ncit0002">[0011]</crossref></li>
<li><nplcit id="ref-ncit0003" npl-type="b"><article><atl/><book><author><name>MOTOICHI INDO</name></author><book-title>Synthetic Perfume, Chemistry and Knowledge on products</book-title><imprint><name>The Chemical Daily Co., Ltd.</name><pubdate>19960000</pubdate></imprint></book></article></nplcit><crossref idref="ncit0003">[0042]</crossref></li>
<li><nplcit id="ref-ncit0004" npl-type="s"><article><author><name>STEFFEN ARCTAMDER</name></author><atl/><serial><sertitle>Perfume and Flavor Chemicals</sertitle><pubdate><sdate>19690000</sdate><edate/></pubdate></serial></article></nplcit><crossref idref="ncit0004">[0042]</crossref></li>
</ul></p>
</ep-reference-list>
</ep-patent-document>
